CSPC Ouyi Pharmaceutical Co., Ltd.
Clinical trials sponsored by CSPC Ouyi Pharmaceutical Co., Ltd., explained in plain language.
Pharmaceutical subsidiary of CSPC Group, developing drugs and generics.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a single injection of SYH2082 help tackle obesity? a first-in-human trial puts safety to the test. Results expected Sep 2026 (estimated)
- New triple therapy aims to tame type 2 diabetes Results expected Oct 2026 (estimated)
- New injection aims to ease pain after abdominal surgery Results expected Dec 2026 (estimated)
- New pill could help millions with stubborn high cholesterol Results expected Jun 2027 (estimated)